{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:22:52Z","timestamp":1793798572167,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017117","name":"Denali Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ymgme.2026.109862","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:20:33Z","timestamp":1771546833000},"page":"109862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Age-dependent reference intervals for cerebrospinal fluid and urine biomarkers of mucopolysaccharidoses"],"prefix":"10.1016","volume":"147","author":[{"given":"Candice B.","family":"Herber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah S.","family":"Gho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Claire L.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyankhishig","family":"Tsogtbaatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung H.","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Huntwork-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Model","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Ireton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuda","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie D.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie L.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.109862_bb0005","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40265-019-01147-4","article-title":"Therapeutic options for mucopolysaccharidoses: current and emerging treatments","volume":"79","author":"Sawamoto","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2026.109862_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2018.01.003","article-title":"Clinical presentation and diagnosis of mucopolysaccharidoses","volume":"125","author":"Stapleton","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109862_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108507","article-title":"Causes of death in mucopolysaccharidoses","volume":"142","author":"Rintz","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109862_bb0020","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3390\/ijms24010477","article-title":"Mucopolysaccharidoses: cellular consequences of glycosaminoglycans accumulation and potential targets","volume":"24","author":"Leal","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.109862_bb0025","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/biom13030532","article-title":"Mucopolysaccharidoses differential diagnosis by mass spectrometry-based analysis of urine free glycosaminoglycans\u2014a diagnostic prediction model","volume":"13","author":"D'Avanzo","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymgme.2026.109862_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911724","article-title":"Pathogenic roles of heparan sulfate and its use as a biomarker in mucopolysaccharidoses","volume":"23","author":"Minami","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2026.109862_bb0035","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pedneo.2022.10.001","article-title":"Current and new therapies for mucopolysaccharidoses","volume":"64","author":"Penon-Portmann","year":"2023","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/j.ymgme.2026.109862_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108535","article-title":"Community consensus for heparan sulfate as a biomarker to support accelerated approval in neuronopathic mucopolysaccharidoses","volume":"142","author":"Muenzer","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109862_bb0045","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3390\/ijms21082704","article-title":"Biomarkers for lysosomal storage disorders with an emphasis on mass spectrometry","volume":"21","author":"Mashima","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.109862_bb0050","first-page":"103","article-title":"Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and hunter syndrome patients with and without cognitive impairment","volume":"5","author":"Hendriksz","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.109862_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2020.03.004","article-title":"Advances in glycosaminoglycan detection","volume":"130","author":"Khan","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109862_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymgme.2016.09.005","article-title":"Glycosaminoglycans detection methods: applications of mass spectrometry","volume":"120","author":"Kubaski","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109862_bb0065","article-title":"Biomarkers in patients with mucopolysaccharidosis type II and IV","volume":"19","author":"Fujitsuka","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.109862_bb0070","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4155\/bio-2018-0025","article-title":"A novel LC-MS\/MS assay to quantify dermatan sulfate in cerebrospinal fluid as a biomarker for mucopolysaccharidosis II","volume":"10","author":"Pan","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ymgme.2026.109862_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4294","article-title":"Development and validation of an LC-MS\/MS method for the quantitation of heparan sulfate in human urine","volume":"32","author":"Wang","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ymgme.2026.109862_bb0080","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.3390\/ijms21155188","article-title":"Characterization of fluid biomarkers reveals lysosome dysfunction and neurodegeneration in neuronopathic MPS II patients","volume":"21","author":"Bhalla","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.109862_bb0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymgme.2019.05.005","article-title":"Evaluation of biomarkers for Sanfilippo syndrome","volume":"128","author":"Saville","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109862_bb0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2022.07.015","article-title":"The transformation of drug development for the 21st century: time for a change","volume":"137","author":"Kakkis","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109862_bb0095","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nbt.3530","article-title":"Accessing the accelerated approval pathway for rare disease therapeutics","volume":"34","author":"Kakkis","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2026.109862_bb0100","first-page":"442","article-title":"Calculation of continuous reference intervals for biological parameters exhibiting strong age-dependent level changes: its application to glycosaminoglycans and sialic acid in urine","volume":"65","author":"Rodriguez","year":"2024","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.109862_bb0105","series-title":"CLSI C28-A3: Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline\u2014Third Edition","first-page":"1","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.ymgme.2026.109862_bb0110","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1515\/CCLM.2010.319","article-title":"An appraisal of statistical procedures used in derivation of reference intervals","volume":"48","author":"Ichihara","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2026.109862_bb0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1467-9876.2005.00510.x","article-title":"Generalized additive models for location, scale and shape","volume":"54","author":"Rigby","year":"2005","journal-title":"J. R. Stat. Soc.: Ser. C: Appl. Stat."},{"key":"10.1016\/j.ymgme.2026.109862_bb0120","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s13023-024-03463-9","article-title":"Heparan sulfate in cerebrospinal fluid as a biomarker to assess disease severity and for treatment monitoring in patients with mucopolysaccharidosis type II: a position statement","volume":"19","author":"Giugliani","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.109862_bb0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-009-9036-3","article-title":"Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I","volume":"33","author":"Tomatsu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.109862_bb0130","first-page":"116","article-title":"Specific GAG ratios in the diagnosis of mucopolysaccharidoses","volume":"65","author":"Mathis","year":"2024","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.109862_bb0135","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/clinchem\/35.7.1472","article-title":"Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses","volume":"35","author":"de Jong","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2026.109862_bb0140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.clinbiochem.2014.06.012","article-title":"Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population","volume":"47","author":"Komosinska-Vassev","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2026.109862_bb0145","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1203\/01.PDR.0000113767.60140.E9","article-title":"Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA","volume":"55","author":"Tomatsu","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2026.109862_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.pmbts.2017.12.008","article-title":"Gangliosides in nerve cell specification","volume":"156","author":"Itokazu","year":"2018","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ymgme.2026.109862_bb0155","doi-asserted-by":"crossref","first-page":"57R","DOI":"10.1093\/glycob\/cwm018","article-title":"The expression and functions of glycoconjugates in neural stem cells","volume":"17","author":"Yanagisawa","year":"2007","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2026.109862_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.572965","article-title":"Gangliosides in the brain: physiology, pathophysiology and therapeutic applications","volume":"14","author":"Sipione","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymgme.2026.109862_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072566","article-title":"Mechanism of secondary ganglioside and lipid accumulation in lysosomal disease","volume":"21","author":"Breiden","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226001459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226001459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:10:28Z","timestamp":1777608628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226001459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1096719226001459"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109862","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-dependent reference intervals for cerebrospinal fluid and urine biomarkers of mucopolysaccharidoses","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109862"}}